Pharmacy- Page 51

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Roche announces FDA grants Venclexta(venetoclax) accelerated approval

The FINANCIAL -- Roche announced on April 12 that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Venclexta (venetoclax) for the treatment of people with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test,

by The FINANCIAL

April 12, 2016

1 min read

Pharmacy

FDA grants priority review for Roche’s cancer immunotherapy atezolizumab in specific type of lung cancer

The FINANCIAL -- Roche on April 11 announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted Priority Review for atezolizumab (anti-PDL1; MPDL3280A) for the treatment of people with locally advanced or metastatic

by The FINANCIAL

April 11, 2016

1 min read

Pharmacy

AstraZeneca, Eli Lilly in Final Stage of Testing Alzheimer’s Drug

The FINANCIAL -- AstraZeneca and Eli Lilly and Company on April 8 announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for early Alzheimer’s disease, will continue

by The FINANCIAL

April 8, 2016

1 min read

Pharmacy

Novartis Reports EU Approval Of Revolade For Treatment Of Pediatric Chronic ITP

The FINANCIAL -- Novartis announced on April 7 that the European Commission (EC) has approved Revolade (eltrombopag) for the treatment of pediatric (aged 1 year and above) chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients who are refractory to other treatments (e.g. corticosteroids,

by The FINANCIAL

April 7, 2016

1 min read

Pharmacy

Allergan and Heptares Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer’s and Other Neurological Disorders

The FINANCIAL -- Allergan plc and Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation on April 6 announced that Allergan's wholly-owned subsidiary, Allergan Pharmaceuticals International Limited and Heptares have entered into a definitive agreement under which Allergan will license exclusive global

by The FINANCIAL

April 7, 2016

2 mins read

Pharmacy

Pfizer Announces Termination Of Proposed Combination With Allergan

The FINANCIAL -- Pfizer Inc. on April 6 announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies.

by The FINANCIAL

April 6, 2016

1 min read

Pharmacy

FDA Approves INFLECTRA, The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications

The FINANCIAL -- The United States (U.S.) Food and Drug Administration (FDA) on April 5 approved Celltrion’s INFLECTRA (biosimilar infliximab) across all eligible indications of the reference product, Remicade (infliximab).1INFLECTRA is now the first and only biosimilar monoclonal antibody (mAb) therapy, and

by The FINANCIAL

April 6, 2016

1 min read

Pharmacy

Merck And Pfizer Announce First Patient Treated In Phase III Combination Study With Avelumab And INLYTA In Renal Cell Carcinom

The FINANCIAL -- Merck and Pfizer on April 5 announced the treatment of the first patient in a Phase III study of avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, in an advanced renal cell carcinoma (RCC) setting.

by The FINANCIAL

April 6, 2016

1 min read

Pharmacy

Johnson & Johnson Announces Launch of New Global Public Health Strategy at Opening of New Operations in Africa

The FINANCIAL -- Johnson & Johnson on April 5 announced the official launch of its global public health strategy at the opening of its companies’ on-the-ground global public health operations in Cape Town, South Africa.

by The FINANCIAL

April 6, 2016

4 mins read

Pharmacy

Pfizer Announces Positive Top-Line Results From The First Phase 3 Trial Of Investigational Tofacitinib In Adults With Psoriatic Arthritis

The FINANCIAL -- Pfizer Inc. announced on April 5 top-line results from its first Phase 3 study investigating tofacitinib for the treatment of psoriatic arthritis, Oral Psoriatic Arthritis triaL (OPAL) Broaden.

by The FINANCIAL

April 5, 2016

1 min read

Previous 1 … 49 50 51 52 53 … 195 Next

Pharmacy- Page 51

Roche ranked the most sustainable healthcare company in the DJSI

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

Roche announces FDA grants Venclexta(venetoclax) accelerated approval

FDA grants priority review for Roche’s cancer immunotherapy atezolizumab in specific type of lung cancer

AstraZeneca, Eli Lilly in Final Stage of Testing Alzheimer’s Drug

Novartis Reports EU Approval Of Revolade For Treatment Of Pediatric Chronic ITP

Allergan and Heptares Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer’s and Other Neurological Disorders

Pfizer Announces Termination Of Proposed Combination With Allergan

FDA Approves INFLECTRA, The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications

Merck And Pfizer Announce First Patient Treated In Phase III Combination Study With Avelumab And INLYTA In Renal Cell Carcinom

Johnson & Johnson Announces Launch of New Global Public Health Strategy at Opening of New Operations in Africa

Pfizer Announces Positive Top-Line Results From The First Phase 3 Trial Of Investigational Tofacitinib In Adults With Psoriatic Arthritis

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pharmacy- Page 51

Popular Posts

Recent Posts

Get updates

Join

Latest comments